Skin substitutes (SS) can be a vital adjunct to standard of care for achieving wound closure in acute and chronic wounds. However, the variety of SS categories available, and their very high unit cost, often complicated by reimbursement requirements, can make selection challenging, as the physician needs to be able to determine which SS will be both clinically effective and cost-effective for individual patient needs. In this online masterclass, a select group of KOL physicians will debate how to make good SS selection decisions, and then quiz manufacturers/suppliers as to when and why they should use their products.
The masterclass will comprise two parts. The first will be a discussion among key opinion leaders identifying the main challenges relating to the selection of a clinically effective and cost-effective skin substitute (SS) and how they deal with this in their practice. The second part will be a Q&A section, in which the KOLs will ask various manufacturers/suppliers of SSs how they can get the best use out of their product.
Presenters
Dr Claudia M. Barzilay, Ph.D.
Chief Technology Officer at Nanomedic Technologies
Dr. Barzilay has over 15 years of recognized research and development experience in the field of Pharma, Biotech and Medical Devices. Prior to joining Nanomedic, Claudia served in local and global companies as Project Manager, Scientific Advisory and VP R&D, gaining vast knowledge in Product Development, GLP Regulations, Patent writing and Business Development. She received her Ph.D. in Chemistry from the Technion- Israel Institute of Technology, pursued postdoctoral research at Stanford University, CA- USA and achieved a Researcher and Lecturer position at the Hebrew University.